First launch and 2-year trial results announced for SightGlass Vision

SGV Netherlands Launch Event - Oct 5 2021

In conjunction with the commercial launch of the product in the Netherlands, CooperVision released last week the results of the ongoing clinical trial on the performance of its SightGlass Vision lenses in terms of myopia progression reduction after two years of research.

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.